Sickle cell anemia

Sickle cell anemia (SCA) is an autosomal recessive hemoglobinopathy caused by a point mutation in the β-globin gene, producing abnormal hemoglobin S (HbS) that polymerizes under hypoxic conditions and distorts erythrocytes into a sickle shape.[1] The resulting chronic hemolytic anemia and recurrent vaso-occlusion produce multisystem organ damage, including characteristic changes in the jaws and teeth.[2][3] In the maxillofacial skeleton, two principal pathophysiologic mechanisms drive imaging findings: erythroblastic hyperplasia with compensatory medullary expansion, and vaso-occlusive ischemia leading to bone infarction and susceptibility to osteomyelitis.[4][5] The signature dental radiographic pattern is a coarsened trabecular architecture with decreased bone density, often described as a "step-ladder" or "spider-web" pattern in the alveolar bone.[6][7] Management is systemic and multidisciplinary; dental care requires specific precautions to avoid precipitating vaso-occlusive crises.[2][3]

The current preferred term is sickle cell disease (SCD), which encompasses all genotypes producing the clinical syndrome. Sickle cell anemia (SCA) refers specifically to the homozygous HbSS genotype, the most common and typically most severe form.[1][8] Other SCD genotypes include HbSC disease (co-inheritance of βS and βC alleles) and HbS/β-thalassemia.[8] The heterozygous carrier state is termed sickle cell trait (SCT, HbAS) and is generally asymptomatic, though mild jaw bone trabecular changes have been documented.[7][9] Older literature may use "sickle cell crisis" loosely; the current preferred term for the acute painful episode is vaso-occlusive crisis (VOC).[1]

• Approximately 300,000 infants are born annually worldwide with SCD, predominantly in sub-Saharan Africa, India, the Mediterranean, and the Middle East; roughly 100,000 individuals in the United States are affected.[1]
• HbSS accounts for up to 70% of SCD cases in populations of African origin; HbSC disease accounts for up to 30%.[8]
• Orofacial manifestations occur across all age groups. A systematic review and meta-analysis of 28 studies found the pooled prevalence of decreased jaw bone density in SCD to be approximately 57%, the step-ladder trabecular pattern approximately 30%, delayed dental eruption approximately 20%, and malocclusion approximately 66%.[10]
• Osteomyelitis of the jaws is an occasional complication; overall osteomyelitis prevalence in SCD ranges from approximately 0.3% to 12%, with the mandible more commonly affected than the maxilla.[2][11][12]
• Average life expectancy in SCD remains approximately 20 years less than the general population.[1]

Orofacial presentation

• Maxillary protrusion and malocclusion are the most commonly recognized jaw abnormalities, resulting from erythroblastic hyperplasia and medullary expansion of the maxilla; Class II malocclusion is common.[9][10]
• Pallor of the oral mucosa reflects chronic hemolytic anemia; mucosal pallor and scleral icterus may be evident on examination.[2]
• Delayed dental eruption is a recognized feature, particularly in children.[3][10]
• Orofacial pain may occur during VOC, sometimes mimicking odontogenic pain; jaw bone pain can be the presenting complaint of mandibular infarction.[2][13]

Dental complications

• Asymptomatic pulp necrosis results from microvascular occlusion of the pulpal blood supply and may be discovered incidentally on radiographs or vitality testing.[2][3]
• Pulp calcifications are more prevalent in SCA than in controls.[7][9]
• Hypercementosis and external root resorption occur at increased frequency.[9]

Neuropathy

• Mental nerve neuropathy (numb chin syndrome) is an uncommon but well-documented complication, typically presenting as acute unilateral lower lip and chin numbness during VOC; it is attributed to mandibular bone infarction compressing the inferior alveolar or mental nerve. Most episodes are self-limiting, resolving with the VOC, though persistent deficits occur occasionally.[14][15][16]

Infection

• Osteomyelitis of the jaws, particularly the mandible, may present with pain, swelling, fever, and trismus; Salmonella species and Staphylococcus aureus are the most common causative organisms, with geographic variation in pathogen prevalence.[2][11][17]

Location and distribution

Jaw bone changes in SCA are characteristically generalized and bilateral, affecting both the maxilla and mandible.[6][9] The mandibular body and premolar-molar regions are the most frequently evaluated and reported sites, though the maxilla is also commonly involved.[6][9] Trabecular changes in the maxilla and mandible are significantly more prevalent in SCA than in controls.[9]

Internal architecture

The hallmark radiographic finding is an altered trabecular bone pattern resulting from erythroblastic hyperplasia and compensatory medullary expansion.[7][9]

• Step-ladder pattern: Coarse, horizontally oriented trabeculae in the interdental alveolar bone create a characteristic ladder-like appearance; this is the most widely recognized jaw finding in SCA.[6][7][9]
• Spider-web pattern: A less common variant in which coarsened trabeculae radiate in multiple directions, producing a web-like architecture.[6][7]
• Decreased bone density: Generalized reduction in trabecular bone radiodensity with widened medullary spaces is common, reflecting marrow hyperplasia and increased osteoclast activity.[9][10]
• Increased trabecular spacing: Enlarged marrow spaces between coarsened trabeculae are a frequent finding and have been correlated with clinical severity markers such as history of jaundice.[9]

Periphery and lamina dura

• Loss of lamina dura — partial or complete — is significantly more frequent in SCA than in controls, manifesting as loss of sharpness, continuity, or complete absence of the radiopaque line surrounding tooth roots.[6][9]
• Occasional increased thickness of the lamina dura has also been reported in sickle cell trait.[9]

Effects on teeth and adjacent structures

• Pulp calcifications appear as radiopaque masses within the pulp chamber, attributed to accelerated pulp aging from recurrent microvascular ischemia.[7][9]
• Hypercementosis is seen as excessive cementum deposition on root surfaces, more prevalent in sickle cell trait.[9]
• External root resorption is significantly more common in SCA, with prevalence ratios markedly elevated compared to controls.[9]
• Hypotaurodontism has been observed at approximately twice the frequency in SCA compared to controls, though this association has not reached statistical significance in all studies.[6]
• Periapical radiolucencies may represent asymptomatic pulp necrosis secondary to vascular compromise rather than inflammatory disease.[2][3]

Skull and craniofacial changes

• Hair-on-end appearance: Vertical striations of calcified spicules extending perpendicular to the outer table of the skull, visible on lateral skull radiographs, represent a classic but uncommon finding of severe marrow hyperplasia; reported in approximately 5% of SCA patients in one large series. This finding is now rarely encountered in high-income countries due to early diagnosis and optimized care.[18][19]
• Widening of the diploic space with thinning of the outer table is more common than the hair-on-end pattern, seen in approximately 22% of patients.[18]
• Generalized decreased skull bone density is the most frequent calvarial change.[18]

Bone infarction

• Mandibular bone infarction may present as an area of mixed radiolucency and radiopacity, sometimes with periosteal reaction; it is a common cause of acute jaw pain during VOC.[4][13]
• Chronic infarcts may produce sclerotic foci within the medullary bone.

Osteomyelitis

• Radiographic features of jaw osteomyelitis include ill-defined radiolucency, sequestrum formation, periosteal new bone formation, and cortical destruction.[2][4]
• Distinguishing osteomyelitis from bone infarction on conventional radiographs alone is unreliable; clinical correlation and advanced imaging are often required.[20][21]

MRI of jaw bone infarction and osteomyelitis

MRI is the most sensitive modality for detecting acute craniofacial bone infarction in SCD. Characteristic findings include bone marrow edema (low T1, high T2/STIR signal), subperiosteal fluid collections with susceptibility effects suggesting hemorrhage, and heterogeneous enhancement after gadolinium administration.[13] In a series of SCD patients undergoing head and neck MRI, acute craniofacial bone infarcts were found in 15% of those presenting with pain, with the mandible being the most common craniofacial site.[13]

Differentiating osteomyelitis from bone infarction on MRI remains a significant diagnostic challenge, as both produce marrow signal abnormality and periosteal reaction.[12][20] Baseline marrow signal alterations from red marrow hyperplasia, perivascular fibrosis, and hemosiderosis further complicate interpretation.[12] Fat-suppressed T1-weighted gadolinium-enhanced sequences provide the most useful clue: non-enhancing or irregularly enhancing marrow suggests abscess, whereas homogeneous enhancement favors infarction.[12] Large subperiosteal fluid collections (≥4 mm depth), combined with elevated inflammatory markers, favor osteomyelitis over isolated infarction.[20]

MRI of marrow hyperplasia

Reconversion of fatty to hematopoietic marrow produces diffusely low T1 signal throughout the craniofacial skeleton, reflecting replacement of normal fatty marrow by erythroid-hyperplastic marrow.[4][20] Iron deposition from chronic transfusion therapy causes additional signal loss on T2*-weighted and gradient-echo sequences.[4]

The radiographic jaw findings of SCA — generalized decreased bone density, coarsened trabecular pattern, and lamina dura changes — overlap with other systemic conditions that produce marrow expansion or generalized osseous changes. The clinical context (known hemoglobinopathy, ethnicity, age) usually narrows the differential substantially.

The highest-risk diagnostic pitfall is failing to distinguish osteomyelitis from bone infarction in a patient with known SCA presenting with acute jaw pain, fever, and swelling. No single imaging finding reliably differentiates these entities; a multidisciplinary approach integrating clinical assessment, inflammatory markers, MRI, and, when indicated, bone aspiration with culture is essential.[11][20][21]

Bone biopsy is not routinely performed for diagnosis of SCA jaw changes, as the diagnosis is established by hemoglobin electrophoresis and clinical-radiographic correlation. When tissue is obtained — typically during surgical management of osteomyelitis or incidentally — the following findings are characteristic:

• Erythroid hyperplasia: The marrow is normocellular to hypercellular with prominent expansion of the erythroid lineage, reflecting compensatory erythropoiesis in response to chronic hemolysis. Sickle-shaped erythrocytes may be identified within marrow sinusoids.[24][25]
• Trabecular bone remodeling: Increased osteoclast activity with thinned and widely spaced trabeculae corresponds to the radiographic findings of decreased bone density and coarsened trabecular pattern. Vaso-occlusive crises promote osteoclast recruitment, increase bone turnover, and inhibit osteogenesis.[5][7]
• Vascular changes: Arteriosclerotic changes and intimal thickening of small vessels within the marrow and dental pulp result from recurrent vaso-occlusion. These vascular changes contribute to pulp calcification and asymptomatic pulp necrosis.[7]
• Iron deposition: Hemosiderin-laden macrophages may be present in the marrow, particularly in transfusion-dependent patients.[4][25]
• Osteomyelitis: When present, histopathology shows acute or chronic inflammatory infiltrate, necrotic bone (sequestrum), and bacterial colonies; however, histopathology may not definitively exclude bone infarction, and cultures may be falsely negative in patients already receiving antibiotics.[12][21]

The radiologic-pathologic correlation is direct: erythroid hyperplasia and increased osteoclast activity produce the widened medullary spaces and coarsened trabeculae seen on radiographs, while vascular compromise explains the pulp calcifications and periapical changes.[7]

Systemic disease management

SCA management is primarily medical and multidisciplinary. Hydroxyurea remains first-line disease-modifying therapy, increasing fetal hemoglobin and reducing VOC frequency.[1][26] Additional approved agents include L-glutamine and crizanlizumab.[1][26] Hematopoietic stem cell transplant is the only curative therapy but is limited by donor availability; gene therapy is an emerging option.[1][26] Supportive care includes proph